Value of FDG-PET in detecting residual or recurrent nonsmall cell lung cancer
T Bury, JL Corhay, B Duysinx, F Daenen… - European …, 1999 - Eur Respiratory Soc
In order to evaluate the usefulness of 18-fluorodeoxyglucose (FDG) positron emission
tomography (PET) in the assessment of therapeutic effects, a study was performed before …
tomography (PET) in the assessment of therapeutic effects, a study was performed before …
Positron emission tomography for predicting recurrence in stage I lung adenocarcinoma: standardized uptake value corrected by mean liver standardized uptake …
S Shiono, M Abiko, T Okazaki, M Chiba… - European journal of …, 2011 - academic.oup.com
Abstract Objective: F-18 fluorodeoxyglucose (FDG) positron emission tomography (PET) has
become an important staging tool for patients with lung cancer, and determination of the …
become an important staging tool for patients with lung cancer, and determination of the …
Prediction of Survival by [18F]Fluorodeoxyglucose Positron Emission Tomography in Patients With Locally Advanced Non–Small-Cell Lung Cancer Undergoing …
Purpose In this prospective National Cancer Institute–funded American College of
Radiology Imaging Network/Radiation Therapy Oncology Group cooperative group trial, we …
Radiology Imaging Network/Radiation Therapy Oncology Group cooperative group trial, we …
Clinical value of F18-fluorodeoxyglucose positron emission tomography-computed tomography in patients with non-small cell lung cancer after potentially curative …
R Kanzaki, M Higashiyama, J Maeda… - Interactive …, 2010 - academic.oup.com
Objectives: F18-fluorodeoxyglucose positron emission tomography-computed tomography
(FDG-PET/CT), which allows differentiation between malignant and benign lesions based on …
(FDG-PET/CT), which allows differentiation between malignant and benign lesions based on …
Value of FDG PET in the management of NSCLC
D Ukena, D Hellwig - Lung cancer, 2004 - Elsevier
Metabolic imaging with positron emission tomography (PET) using 18F-fluoro-2-deoxy-
glucose (FDG) has been accepted as an important imaging modality in lung cancer. FDG …
glucose (FDG) has been accepted as an important imaging modality in lung cancer. FDG …
Is standardised 18F-FDG uptake value an outcome predictor in patients with stage III non-small cell lung cancer?
SM Eschmann, G Friedel, F Paulsen, M Reimold… - European journal of …, 2006 - Springer
Purpose Recent studies have demonstrated the relevance of 18 F-FDG uptake as an
independent prognostic factor for recurrence of operable non-small cell lung cancer …
independent prognostic factor for recurrence of operable non-small cell lung cancer …
Prognostic value of SUVmax measurements obtained by FDG-PET in patients with non-small cell lung cancer receiving chemotherapy
Y Imamura, K Azuma, S Kurata, S Hattori, T Sasada… - Lung Cancer, 2011 - Elsevier
[18F] Fluorodeoxyglucose (FDG) uptake has been shown to correlate well with tumor
proliferation rates. In patients with non-small cell lung cancer (NSCLC) receiving …
proliferation rates. In patients with non-small cell lung cancer (NSCLC) receiving …
Sensitivity of FDG PET, GLUT1 expression and proliferative index in bronchioloalveolar lung cancer
AH Khandani, KD Whitney, SM Keller… - Nuclear medicine …, 2007 - journals.lww.com
Objective To estimate the sensitivity of [18 F] fluorodeoxyglucose (FDG) positron emission
tomography (PET) and to assess the expression of glucose transporter 1 (GLUT1) and …
tomography (PET) and to assess the expression of glucose transporter 1 (GLUT1) and …
Non-small cell lung cancer: FDG PET for nodal staging in patients with stage I disease
MA Farrell, HP McAdams, JE Herndon, EF Patz Jr - Radiology, 2000 - pubs.rsna.org
PURPOSE: To determine the accuracy of 2-[fluorine-18] fluoro-2-deoxy-d-glucose (FDG)
positron emission tomography (PET) in the evaluation of regional lymph nodes in patients …
positron emission tomography (PET) in the evaluation of regional lymph nodes in patients …
Relationship between primary lesion FDG uptake and clinical stage at PET–CT for non-small cell lung cancer patients: An observation
M Li, Y Sun, Y Liu, A Han, S Zhao, L Ma, J Zheng, J Yu - Lung Cancer, 2010 - Elsevier
The aim of the present study was to investigate the relationship between FDG uptake and
clinical stage for non-small cell lung cancer. The patients who were histologically or …
clinical stage for non-small cell lung cancer. The patients who were histologically or …